Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Intec has entered into an agreement with Novartis to explore using the Accordion Pill platform for a proprietary compound.
read more
Intec Pharma has entered into a new research collaboration agreement with MSD, the tradename of Merck & Co. Details of the agreement are confidential.
read more
Intec Pharma has partnered with LTS for the manufacture of the Accordion Pill Carbidopa/Levodopa as a treatment for Parkinson's Disease symptoms.
read more
Wednesday, March 31, 2021
INTEGRA Biosciences celebrated the expansion of its state-of-the-art facility in Hudson, NH, with a community ribbon cutting ceremony.
read more
Integra LifeSciences has announced a partnership with Tissue Analytics, an AI-powered software solution for wound assessment and monitoring.
read more
INTEGRA’s Australian distributor, BioTools, has partnered with SNP to support COVID-19 testing using the ASSIST PLUS pipetting robot, helping the laboratory team to increase sample processing capacity and fast track COVID-19 assay development while ...
read more
Tuesday, September 18, 2018
Integral Molecular and Merus N.V. announced they have entered into a collaboration on multiple undisclosed targets.
read more
Integral Molecular has successfully reached the first milestone in its collaboration with Daiichi Sankyo to discover new immuno-oncology (I-O) therapeutic targets.
read more
Integrated DNA Technologies (IDT), a Danaher company, announced the expansion of its manufacturing footprint in Coralville, Iowa. The investment delivers a more than threefold increase in synthesis capacity, enabling faster, more scalable production ...
read more
IntegriChain has acquired Cumberland's Life Science Division, a provider of managed services, advisory services and systems integration for contracts, pricing and revenue management.
read more
Monday, February 05, 2018
IntegriChain announced the acquisition of Medical Communication Technologies (MCT).
read more
Wednesday, April 19, 2017
IntegriChain has announced the acquisition of PharmaMetrics, a provider of contract operations outsourcing and market access analytics software and services. The acquisition strengthens IntegriChain's ability to deliver industry-leading analytics and...
read more
Thursday, December 28, 2017
Integrity Applications has entered into an exclusive distribution agreement with MediReva for the GlucoTrack in the Netherlands.
read more
Monday, February 14, 2022
Curia, formerly AMRI, announced that Integrity Bio and LakePharma, two companies that it acquired last year, have fully transitioned to the Curia brand. This change reflects the accelerated organizational integration of the acquired companies into ...
read more
IntelGenx Corp. announced that it has received an amended Drug Establishment License (“DEL”) from Health Canada, allowing the Company to conduct third-party testing.
read more